Clinical Trial Update: 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated 18F-fluorocholine PET/MR for staging high-risk prostate cancer. The study was conducted by University Health Network, Toron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Fluorocholine (18F) (18F-fluorocholine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | NA | Status: COMPLETED